Ina Poser

Research & Development
Ina Poser

Ina leads the Dresden HTS / IVP and Automation team. Before joining Dewpoint in March 2019 as one of the first team members, she was a staff scientist and project manager at the Max-Planck Institute of Cell Biology and Genetics (MPI-CBG) in Dresden, Germany, working together with Tony Hyman for 15 years.

She began her career at MPI-CBG as a postdoctoral student working at the screening facility. Soon after joining the Tony Hyman lab, Ina was leading a team of research assistants generating stable BAC transgenic Hela cell lines in high throughput as part of the EU-funded projects MitoCheck and MitoSys. Additionally, she was closely involved in the Hyman lab’s ALS project, including iPS modification using CRISPR/Cas9, optimization of cell differentiation protocols to obtain motor neurons, and stress assays.

Ina started her scientific career by studying Diplom-Biology in Jena, Germany, then moving to Rostock on the Baltic Sea to complete her studies. There, she also studied marine biology and became acquainted with cell culture applications by doing her diploma thesis on the influence of asbestos on human primary mesothelial cells. She began her Ph.D. work at the University Hospital Aachen, focusing on the molecular mechanisms of melanoma progression and metastasis, including cell-based in vitro and in vivo models.

She completed her Ph.D. in Regensburg, Germany, after moving there with her first boss Professor Anja Bosserhoff, to start and build up a new lab.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science